El uso de medicamentos para reducir el riesgo de cáncer de mama primario: una revisión sistemática de los Servicios Preventivos de Estados Unidos

Autores
Categoría Resumen estructurado de revisiones sistemáticas
RevistaDatabase of Abstracts of Reviews of Effects (DARE)
Año 2013
Cargando información sobre las referencias

CRD SUMMARY:

The authors concluded that tamoxifen and raloxifene reduced the incidence of invasive breast cancer and fractures, but increased the incidence of thromboembolic events. Tamoxifen was more effective than raloxifene, but it increased the incidence of endometrial cancer and cataracts. Overall, these conclusions are likely to be reliable.
Epistemonikos ID: 802be5dbce7171ba95ddff8fbfbee445372709c6
First added on: Jan 13, 2015